PRME short interest
Prime Medicine Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 32,116,376 |
|---|---|
| Change vs prior report | -15,842 (-0.1%) |
| Change over six months | +7.2% |
| Days to cover | 8.45 (sector: 3.78) |
| Average daily volume | 3,802,941 |
| Rank in Healthcare | #181 of 922 by days to cover |
PRME short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 32,116,376 | -0.1% | 8.45 | 3,802,941 |
| 2026-09-15 | 32,132,218 | -12.6% | 12.31 | 2,610,870 |
| 2026-08-31 | 36,761,940 | +5.0% | 13.13 | 2,798,970 |
| 2026-08-14 | 35,022,290 | +0.1% | 13.82 | 2,533,307 |
| 2026-07-31 | 35,003,578 | +4.4% | 12.90 | 2,714,294 |
| 2026-07-15 | 33,536,516 | -3.4% | 6.74 | 4,978,508 |
| 2026-06-30 | 34,729,797 | +6.8% | 9.11 | 3,810,751 |
| 2026-06-15 | 32,533,956 | +5.6% | 11.28 | 2,883,767 |
| 2026-05-29 | 30,820,036 | +1.0% | 11.21 | 2,749,345 |
| 2026-05-15 | 30,528,072 | +0.6% | 11.73 | 2,601,566 |
| 2026-04-30 | 30,352,640 | +0.4% | 18.65 | 1,627,834 |
| 2026-04-15 | 30,235,597 | +0.9% | 16.27 | 1,858,309 |
| 2026-03-31 | 29,959,086 | +11.8% | 11.27 | 2,657,339 |
| 2026-03-13 | 26,809,634 | -1.6% | 9.84 | 2,725,288 |
| 2026-02-27 | 27,246,340 | -3.0% | 9.16 | 2,975,183 |
| 2026-02-13 | 28,078,872 | +3.7% | 10.93 | 2,569,101 |
| 2026-01-30 | 27,079,706 | +3.0% | 9.23 | 2,932,835 |
| 2026-01-15 | 26,301,427 | +2.5% | 7.30 | 3,602,977 |
| 2025-12-31 | 25,672,632 | +17.3% | 6.26 | 4,101,754 |
| 2025-12-15 | 21,886,408 | +11.2% | 6.35 | 3,447,020 |
| 2025-11-28 | 19,673,466 | +5.8% | 5.01 | 3,925,834 |
| 2025-11-14 | 18,603,374 | +2.1% | 4.86 | 3,831,513 |
| 2025-10-31 | 18,214,907 | +15.5% | 4.85 | 3,752,909 |
| 2025-10-15 | 15,774,156 | -21.2% | 3.35 | 4,705,689 |
| 2025-09-30 | 20,012,461 | +4.7% | 5.17 | 3,872,248 |
import finzdata as yf
yf.Ticker("PRME").short_interest # every report since 2017
yf.Client().short_interest(["PRME"], start="2018-01-01")Healthcare short interest · PRME price history · Who owns PRME · All short interest